Coloplast A/S (OTCMKTS:CLPBY) Sees Large Volume Increase - Should You Buy?

Key Points

• Trading spike: Shares saw about a 98% increase in volume to ~1.18M shares on Tuesday while the stock traded down roughly 4.4% to $6.6050 from a $6.86 close.
• Quarterly results: Coloplast reported $0.10 EPS, beating the $0.09 estimate, but revenue of $1.11B slightly missed the $1.12B consensus; net margin was 14.35% and ROE 27.87%.
• Analyst stance & valuation: Sanford C. Bernstein raised the stock to a "Hold" and the consensus rating is "Hold," with a market cap of $14.78B and a PE ratio of 24.30.

Shares of Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY - Get Free Report) saw unusually-strong trading volume on Tuesday . Approximately 1,180,780 shares traded hands during mid-day trading, an increase of 98% from the previous session's volume of 596,942 shares.The stock last traded at $6.6050 and had previously closed at $6.86.

Wall Street Analyst Weigh In

Separately, Sanford C. Bernstein raised shares of Coloplast A/S to a "hold" rating in a research note on Wednesday, January 28th. Three analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock currently has an average rating of "Hold".

Coloplast A/S Stock Down 4.4%

The company has a market cap of $14.78 billion, a PE ratio of 24.30, a P/E/G ratio of 0.73 and a beta of 0.50. The company's 50 day moving average is $7.42 and its 200 day moving average is $8.39. The company has a current ratio of 1.30, a quick ratio of 0.81 and a debt-to-equity ratio of 1.50.

Coloplast A/S (OTCMKTS:CLPBY - Get Free Report) last posted its quarterly earnings results on Friday, February 6th. The company reported $0.10 EPS for the quarter, topping the consensus estimate of $0.09 by $0.01. The company had revenue of $1.11 billion for the quarter, compared to the consensus estimate of $1.12 billion. Coloplast A/S had a net margin of 14.35% and a return on equity of 27.87%. As a group, analysts predict that Coloplast A/S Sponsored ADR will post 0.31 earnings per share for the current fiscal year.

About Coloplast A/S

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast's offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.